THC

Tenet Healthcare's stock price has been impacted by several key events in the past six months. The company reported strong first-quarter 2026 results, with earnings per share (EPS) significantly surpassing expectations. In February 2026, Tenet announced the completion of a strategic transaction with CommonSpirit Health, resuming full ownership of its Conifer Health Solutions subsidiary. Over the past 52 weeks, Tenet Healthcare's stock has traded between a low of $146.60 and a high of $247.21. Analysts have largely maintained "Buy" or "Overweight" ratings, with a consensus price target around $242.89 to $264, implying potential upside. Insider selling of shares has also been noted during this period.